To improve PSA tests, a number of approaches have been investigated in the past, including isoforms of PSA such as free PSA and proPSA [22], new cancer biomarkers such as PCA3 [23], as well as combinatory assays measuring PSA and other parameters such as AMACR [24,25]. The gene discussed is PCA3; the disease is cancer.